
Surrozen
(NASDAQ) SRZN
Surrozen Financials at a Glance
Market Cap
$274.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$7.49M
Net Income (TTM)
-$342.56M
EPS (TTM)
-$41.32
P/E Ratio
-0.57
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$23.27
Volume
199,398.259
Open
$23.79
Price
$23.27
Volume
199,398.259
Open
$23.79
Previous Close
$23.01
Daily Range
$22.00 - $24.49
52-Week Range
$8.20 - $35.00
Estimated Earnings Date
Aug 14, 2026
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$23.27
Volume
199,398.259
Open
$23.79
Previous Close
$23.01
Daily Range
$22.00 - $24.49
52-Week Range
$8.20 - $35.00
Estimated Earnings Date
Aug 14, 2026
SRZN News
SRZN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Surrozen
Industry
Biotechnology
Sector
Health CareEmployees
44
CEO
Craig C. Parker, MBA
Website
www.surrozen.comHeadquarters
South San Francisco, CA 94080, US
SRZN Financials
Key Financial Metrics (TTM)
Gross Margin
99.13%
Operating Margin
-573.75%
Net Income Margin
-4571.14%
Return on Equity
309.79%
Return on Capital
N/A
Return on Assets
-283.79%
Earnings Yield
-1.75%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$274.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
11.61M
Volume
199.40K
Avg. Volume
131.89K
Financials (TTM)
Gross Profit
$7.43M
Operating Income
-$43.00M
EBITDA
-$342.25M
Operating Cash Flow
-$33.46M
Capital Expenditure
-$221.00K
Free Cash Flow
-$33.68M
Cash & ST Invst.
$106.91M
Total Debt
$6.78M
Surrozen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.00M
+408.6%
Gross Profit
$4.94M
+402.0%
Gross Margin
98.70%
N/A
Market Cap
$274.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$6.54M
N/A
Employees
42
N/A
Net Income
-$127.51M
-372.8%
EBITDA
-$127.44M
-377.7%
Quarterly Fundamentals
Total Cash
$106.91M
+5.2%
Total Debt
$6.78M
-14.9%
Accounts Receivable
$5.00M
+90.0%
Inventory
$0.00
N/A
Long Term Debt
$4.85M
-28.4%
Short Term Debt
$1.93M
+61.9%
Return on Assets
-2.84%
N/A
Return on Invested Capital
-38.69%
N/A
Free Cash Flow
-$12.62M
-35.6%
Operating Cash Flow
-$12.50M
-34.7%
